MAD2L2 and diffuse large B-cell lymphoma: Interestingly, high REV-7 expression was associated with significantly lower overall survival (OS) and PFS, while it was also an independent prognostic factor of poor prognosis in diffuse large B‐cell lymphoma patients [16].